About Allay Therapeutics
Allay Therapeutics is a private company based in San Jose, California. It has reported $162,643,150 raised in four offerings on Form D since February 2019. Its chief executive is Adam Gridley.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 24, 2025 | Feb 10, 2025 | $44,999,997of $59.9M target | 18 | $2.4M | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 9, 2021 | Sep 20, 2021amended Dec 21, 2023 | $86,890,346fully sold | 22 | $3.9M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Apr 17, 2020 | May 1, 2020amended Jul 8, 2021 | $15,000,000of $18.0M target | 7 | $2.1M | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 31, 2019 | Feb 12, 2019 | $15,752,807of $28.7M target | 14 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $162,643,150 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Allay Therapeutics's Form D filed Feb 10, 2025.
LR
Leighton Read
Director
MD
NV
MC
TL
Tiffany Le
Director
AG
Adam Gridley
Chief Executive Officer and director
PM
Paul McCreadie
Director
JL
J.c. Lopez
Director
AT
Anselm Tan
Director
KH
Kristen Howells
Executive officer
Earlier filings also listed Tak Cheung (director, last listed Dec 2023), Josh Makower (director, last listed Dec 2023), Karun Naga (director, last listed Jul 2021) and Hanson Gifford III (director, last listed Feb 2019).